2Fuster V,Ryden LE,Cannom DS,et a1.2011ACCF/AHA/HRSfocused updates incorporated into the ACC/AHA/ESC2006 Guidelines for the management of patients with atrial fibrillation:a report of the american college of cardiology foundation/american heart association task force on practice guidelines developed in partnership with the european society of cardiology and in collabo-ration with the european heart rhythm association and the heart rhythm society[J].Journal of the American College of Cardiology,2011,57(11):101.
9Vos MA.Early rate control in complete atfioventrieular block is warranted to prevent electrical remodeling:no role for ven-trieuhr activation[J].Heart Rhythrn,2005,2(3):301.
二级参考文献40
1Nattel S,Burstein B,Dobrev D.Atrial remoldeling and atrial fibrillation mechanism and implications.Circ Arrhythm Electrophysiol,2008,1:62-73.
2Burstein B,Nattel S.Atrial fibrosis:mechanisms and clinical relevance in atrial fibrillation.J Am Coil Cardiol,2008,51:802-809.
3Allessie M,Ausma J,Schotten U.Electrical,contractile and structural remodeling during atrial fibrillation.Cardiovasc Res,2002,54:230-246.
4Wijffels MC,Kirehhof CJ,Dorland R,et al.Atrial fibrillation begets atrial fibrillation.A study in awake chronically instrumented goats.Circulation,1995,92:1954-1968.
5De Simone A,De Pasquale M,De Matteis C,et al.Verapamil plus antiarrhythmic drugs reduce atrial fibrillation recurrences after an electrical cardioversion (VEPARAF Study).Eur Heart J,2003,24:1425-1429.
6Fetsch T,Bauer P,Engberding R,et al.Prevention of atrial fibrillation after cardioversion:results of the PAFAC trial.Eur Heart J,2004,25:1385-1394.
7Nishida K,Fujiki A,Sakamoto T,et al.Bepridil reverses atrial electrical remodeling and L-type calcium channel downregulation in a canine model of persistent atrial tschycatdia.J Cardiovasc Eleetrophysiol,2007,18:765 -772.
8Laily JA,Gnall EM,Seltzer J,et al.Non-antiarrhythmic drugs in atrial fibrillation:a review of non-antiarrhythmie agents in prevention of atrial fibrillation.J Cardiovasc Electrophysiol,2007,18:1222-1228.
9GISSI-AF Investigators,Disertori M,Latini R,et al.Valsartan for prevention of recurrent atrial fibrillation.N Engl J Med,2009,360:1606-1617.
10VOS M A, GOLITSYN S R, STANGL K, et al. Superiority of Ibutilide (a newclass Ⅲ agent) over DL- sotalol in converting atrial flutter and atrial fibrillation [J]. Heart,1998,79:568-575.
